Covishield Vaccine Details - Summary
This content provides essential information about the Covishield vaccine and its details. The Covishield vaccine has been granted a restricted use license for emergency situations, allowing it to be used for the active immunization of individuals aged 18 years and older to prevent coronavirus disease 2019 (COVID-19).
The COVISHIELD™ vaccine protects against COVID-19, which is caused by the SARS-CoV-2 virus. It is specifically approved for restricted use in emergency situations, helping individuals aged 18 and above to potentially avoid getting COVID-19 disease.
To get vaccinated with COVISHIELD, individuals must take two doses of 0.5 ml each. The second dose should ideally be administered between 4 to 6 weeks after the first dose. However, research from other countries allows for the second dose to be given up to 12 weeks after the first dose.
Current clinical trials show that the COVISHIELD™ vaccine helps prevent COVID-19 disease if two doses are received between 4 to 12 weeks apart. The length of time that protection lasts after vaccination is still unknown. Generally, a protective immune response may start to develop about 4 weeks after receiving the second dose of the COVISHIELD™ vaccine.
Side Effects of the COVISHIELD Vaccine
Common Reactions
Very Common (may affect more than 1 in 10 people):
- Tenderness, pain, warmth, redness, itching, swelling, or bruising at the injection site
- Feeling unwell or very tired (fatigue)
- Chills, feeling feverish, or headache
- Nausea or feeling sick
- Joint pain or muscle ache
Common (may affect up to 1 in 10 people):
- A lump at the injection site
- Fever
- Vomiting
- Flu-like symptoms, including high temperature, sore throat, runny nose, cough, and chills
Uncommon (may affect up to 1 in 100 people):
- Dizziness or decreased appetite
- Abdominal pain
- Enlarged lymph nodes, excessive sweating, itchy skin, or rash
Please note that these may not be all the possible side effects of the COVISHIELD vaccine. Serious and unexpected side effects may occur, as the COVISHIELD vaccine is still under study in clinical trials.
For more details, download the Covishield Vaccine Details in PDF format using the link given below.
